BCOR yields 3.85% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, BCOR + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCOR + MRK for your $10,000?
BCOR targets bitcoin adopters, which the index defines as companies that have a reported ownership of at least 100 bitcoin as a corporate treasury asset. The fund includes firms of any size and industry listed in developed or emerging markets that meet the indexs minimum market-cap, liquidity, and trading requirements. Eligible securities are categorized as either: i) primary companies, which are firms that own at least 100 bitcoin in their treasury holdings, or ii) secondary companies, which include firms that, aside from owning bitcoin, generate at least 50% of their revenue from bitcoin mining. Holdings are weighted based on the function of their bitcoin holdings in corporate treasury and their free-float market capitalization. Individual security weights are capped at 20% and 2.5% for primary and secondary companies, respectively. In addition, the total weight of secondary companies is capped at 20%. The index reconstitutes and rebalances quarterly.
Full BCOR Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.